At Aisthesis Medical, we are committed to transforming sepsis care through AI-driven early detection
We are proud to announce that Aisthesis Medical has been awarded the City St George’s University of London SME Innovation Voucher Award to conduct a retrospective external clinical validation of our VIOSync Sepsis Prediction Index, in collaboration with St George’s Hospital.
Why This Matters
Sepsis remains one of the leading causes of mortality worldwide, responsible for 11 million deaths annually. Rapid detection is critical, as every hour of delay increases the mortality risk by 8%.
At Aisthesis Medical, we are committed to transforming sepsis care through AI-driven early detection. VIOSync leverages real-time patient data and predictive algorithms to identify sepsis risk earlier—potentially improving patient outcomes by 30% and saving hospitals millions in preventable costs.
Advancing Clinical Validation
This award will allow us to rigorously validate VIOSync’s accuracy, reliability, and clinical impact in real-world settings. Partnering with renowned clinical experts, including Prof. Andrew Rhodes, Dr. Dagan Lonsdale, and Dr. Rhodri Handslip, we aim to further establish VIOSync as a trusted AI-powered decision support system for healthcare professionals.
Looking Ahead
This is a significant milestone in our mission to revolutionize AI-driven healthcare solutions. As we move forward with clinical validation, we remain dedicated to delivering impactful, data-driven innovations that enhance patient care and outcomes.
Stay tuned for updates as we continue to push the boundaries of AI in medicine!
About Aisthesis Medical
Aisthesis Medical is a deep-tech medtech startup developing cutting-edge AI-driven solutions to revolutionize acute care. Founded in 2022, our mission is to save lives by predicting and preventing sepsis before it becomes fatal. Aisthesis Medical is revolutionizing acute care with VIOSync, the first holistic AI-driven sepsis care platform that goes beyond early prediction to guide clinical intervention and optimize patient outcomes. VIOSync, predicts sepsis up to 48 hours earlier, integrates directly into hospital workflows, and optimizes treatment pathways to reduce unnecessary antibiotic use.